Scrip is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


Actavis-Bioton joint venture

Latest From Actavis-Bioton joint venture

Biocon Hopes For EU Insulin Launch In Two Years; Pushes On With A Maturing Pipeline

India’s Biocon moves forward with recombinant insulin in Europe while working on its own innovative biologics pipeline for emerging markets. With that dual strategy, Biocon expects big triggers for growth.

BioPharmaceutical India
See All

Company Information

  • Industry
  • Biotechnology
    • Large Molecule
  • Pharmaceuticals
  • Therapeutic Areas
  • Metabolic Disorders
  • Alias(es)
  • Ownership
  • Private
  • Headquarters
  • Parent & Subsidiaries
  • Actavis-Bioton joint venture
  • Senior Management
  • Contact Info
  • Actavis-Bioton joint venture